Delivery Order SPE2DB22D2006-SPE2DB25FW3VP
- Not listed
- The Defense Logistics Agency awarded a $10,655.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of September 5, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement designated SPE2DX and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $41,362.00 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,023.98 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a completion date of November 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supplies sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units under a firm fixed-price contract valued at $9,772.24. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of November 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed price contract valued at $31,065.33. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,585.79 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The product will...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% patches (30-count) with a firm fixed price structure and completion date of December 12, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.66 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of November 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,291.16 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3VPDelivery Order
The Defense Logistics Agency awarded a $9,610.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch in a 30-count configuration, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and is well-positioned to fulfill this medical supply requirement given its established role as a critical vendor for federal military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a primary pharmaceutical supplier for the Defense Health Agency and other federal healthcare entities through its comprehensive global pharmaceutical support vehicle. The company maintains an extensive portfolio of medical product deliveries including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for topical pain management medication supports DLA's medical supply chain operations and reflects the competitive, open-market procurement approach the agency employs with established prime vendors to ensure cost-effective access to essential pharmaceutical products for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 8/25/25 |